Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Volixibat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Volixibat Data from Mirum's VANTAGE PBC Study Showcased at EASL
    Volixibat Data from Mirum's VANTAGE PBC Study Showcased at EASL

    09 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250509189818/en/Volixibat-Data-from-Mirums-VANTAGE-PBC-Study-Showcased-at-EASL

    BUSINESSWIRE
    09 May 2025
    Share Share
    Mirum Pharma to Showcase Livmarli & Volixibat Data at AASLD
    Mirum Pharma to Showcase Livmarli & Volixibat Data at AASLD

    14 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241114053418/en

    BUSINESSWIRE
    14 Nov 2024
    Share Share
    Mirum’s Volixibat Achieves Positive Interim Analyses In VANTAGE PBC
    Mirum’s Volixibat Achieves Positive Interim Analyses In VANTAGE PBC

    17 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240617178174/en

    BUSINESSWIRE
    17 Jun 2024
    Share Share
    Mirum To Host Call On Volixibat VANTAGE VISTAS Interim Analysis
    Mirum To Host Call On Volixibat VANTAGE VISTAS Interim Analysis

    16 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240616032628/en

    BUSINESSWIRE
    16 Jun 2024
    Share Share
    Mirum Pharma to Showcase Analyses From Its Rare Liver Disease Programs at ILC
    Mirum Pharma to Showcase Analyses From Its Rare Liver Disease Programs at ILC

    16 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210616005316/en/Mirum-Pharmaceuticals-to-Showcase-Analyses-From-Its-Rare-Liver-Disease-Programs-at-The-International-Liver-Congress-2021

    BUSINESSWIRE
    16 Jun 2021
    Share Share
    Mirum spells out plans to turn Shire discards into orphan liver drug successes
    Mirum spells out plans to turn Shire discards into orphan liver drug successes

    24 Jun 2019

    // Amber Tong ENDPTS

    https://endpts.com/in-86m-ipo-pitch-mirum-spells-out-plans-to-turn-shire-discards-into-orphan-liver-drug-successes/

    Amber Tong ENDPTS
    24 Jun 2019
    Share Share